Gossamer Bio, Inc.
NASDAQ:GOSS
0.887 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 95.842 | 0 | 6.784 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.992 | 0.986 | 1.006 | 1.101 | 1.151 | 1.14 | 1.123 | 1.11 | 1.099 | 1.097 | 1.282 | 1.314 | 1.297 | 1.274 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 94.85 | -0.986 | 5.778 | -1.101 | -1.151 | -1.14 | -1.123 | -1.11 | -1.099 | -1.097 | -1.282 | -1.314 | -1.297 | -1.274 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.99 | 0 | 0.852 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 34.836 | 32.392 | 29.678 | 31.2 | 36.309 | 37.795 | 41.508 | 44.509 | 42.58 | 42.322 | 40.932 | 43.19 | 44.318 | 41.827 | 38.91 | 41.846 | 38.684 | 41.414 | 42.596 | 40.148 | 35.676 | 24.983 | 25.872 | 18.857 | 7.93 | 2.624 | 0.675 | 0.212 | 0.002 | 0.002 |
| General & Administrative Expenses
| 8.669 | 9.567 | 9.057 | 9.29 | 9.976 | 10.132 | 12.834 | 11.497 | 11.277 | 12.001 | 10.714 | 12.459 | 11.263 | 11.346 | 15.877 | 11.448 | 11.655 | 10.748 | 11.591 | 9.838 | 9.673 | 8.034 | 13.935 | 22.906 | 4.606 | 2.604 | 0.157 | 0.076 | 0.015 | 0.015 |
| Selling & Marketing Expenses
| -0.742 | 0 | -0.714 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.927 | 9.567 | 8.343 | 9.29 | 9.976 | 10.132 | 12.834 | 11.497 | 11.277 | 12.001 | 10.714 | 12.459 | 11.263 | 11.346 | 15.877 | 11.448 | 11.655 | 10.748 | 11.591 | 9.838 | 9.673 | 8.034 | 13.935 | 22.906 | 4.606 | 2.604 | 0.157 | 0.076 | 0.015 | 0.015 |
| Other Expenses
| 2.747 | 2.816 | 3.808 | 3.42 | 6.538 | 1.69 | 1.456 | -0.332 | 0.587 | -0.199 | 0.078 | 0.115 | 0.457 | 0.149 | -0.13 | -4.243 | -1.531 | 0.893 | 1.089 | 1.486 | 1.851 | 0.376 | 0.319 | 0.622 | 0.3 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 42.763 | 41.959 | 38.021 | 40.49 | 46.285 | 47.927 | 54.342 | 56.006 | 53.857 | 54.323 | 51.646 | 55.649 | 55.581 | 53.173 | 54.787 | 53.294 | 50.339 | 52.162 | 54.187 | 49.986 | 45.349 | 33.017 | 39.807 | 41.763 | 12.536 | 5.228 | 0.832 | 0.288 | 0.017 | 0.017 |
| Operating Income
| 52.087 | -41.959 | -39.027 | -40.49 | -46.3 | -47.942 | -54.357 | -56.021 | -53.872 | -54.343 | -51.661 | -55.664 | -55.596 | -53.203 | -60.087 | -53.569 | -65.339 | -54.967 | -55.787 | -49.986 | -46.349 | -34.017 | -39.807 | -50.024 | -33.036 | -26.126 | -6.332 | -0.288 | -0.017 | -0.017 |
| Operating Income Ratio
| 0.543 | 0 | -5.753 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.58 | 0.031 | -9.121 | 3.42 | 6.523 | -1.223 | -1.407 | -3.342 | -2.594 | -3.442 | 0.063 | 0.1 | 0.442 | 0.119 | -5.43 | -4.518 | -16.531 | -1.912 | -0.511 | 1.486 | 0.851 | -0.624 | 0.319 | -7.639 | -20.2 | -20.898 | -0.118 | 0 | 0 | 0 |
| Income Before Tax
| 53.667 | -41.928 | -48.148 | -40.008 | -42.496 | -49.165 | -55.764 | -59.363 | -56.466 | -57.785 | -56.284 | -60.247 | -59.832 | -57.641 | -64.604 | -57.812 | -66.87 | -54.074 | -54.698 | -48.5 | -44.498 | -32.611 | -38.794 | -49.402 | -32.736 | -26.037 | -6.45 | -0.288 | -0.017 | -0.017 |
| Income Before Tax Ratio
| 0.56 | 0 | -7.097 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 4.435 | -0.986 | -21.453 | 6.763 | 9.967 | 4.723 | 1.422 | 3.342 | 2.594 | 3.442 | -19.44 | 5.004 | 5.291 | 4.929 | 3.414 | -0.902 | 15 | 2.805 | -0.864 | 0 | 0.795 | 0.395 | 0.323 | 8.261 | 20.5 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| 49.232 | -41.928 | -48.148 | -40.008 | -42.496 | -53.888 | -57.186 | -62.705 | -59.06 | -61.227 | -56.284 | -60.247 | -59.832 | -57.641 | -64.604 | -57.812 | -66.87 | -54.074 | -54.698 | -48.5 | -44.498 | -32.611 | -38.794 | -49.402 | -32.736 | -26.037 | -6.45 | -0.288 | -0.017 | -0.017 |
| Net Income Ratio
| 0.514 | 0 | -7.097 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.22 | -0.19 | -0.21 | -0.21 | -0.45 | -0.57 | -0.61 | -0.69 | -0.77 | -0.81 | -0.74 | -0.8 | -0.8 | -0.78 | -0.88 | -0.8 | -1 | -0.87 | -0.89 | -0.8 | -0.74 | -0.9 | -1.56 | -1.99 | -1.32 | -1.05 | -0.26 | -0.031 | -0.002 | -0.002 |
| EPS Diluted
| 0.21 | -0.19 | -0.21 | -0.21 | -0.45 | -0.57 | -0.61 | -0.69 | -0.77 | -0.81 | -0.74 | -0.8 | -0.8 | -0.78 | -0.88 | -0.8 | -1 | -0.87 | -0.89 | -0.8 | -0.74 | -0.9 | -1.56 | -1.99 | -1.32 | -1.05 | -0.26 | -0.031 | -0.002 | -0.002 |
| EBITDA
| 53.079 | -41.959 | -38.021 | -35.577 | -37.901 | -45.65 | -52.292 | -54.763 | -51.871 | -53.201 | -51.332 | -54.029 | -53.686 | -51.557 | -54.551 | -53.019 | -34.352 | -48.462 | -52.587 | -49.735 | -44.349 | -31.423 | -38.656 | -33.377 | 7.996 | -5.133 | -0.832 | 0 | 0 | 0 |
| EBITDA Ratio
| 0.554 | 0 | -5.605 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |